Michael Coslovsky

Head Data Analysis

University of Basel

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Medical Imaging Medical Imaging professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Coslovsky is the Head of Data Analysis at the University of Basel, Switzerland. His research primarily focuses on atrial fibrillation, encompassing areas such as cost-effectiveness analyses, health-related quality of life, and the role of biomarkers in predicting patient outcomes. Recent publications highlight his work on the REACT-HF score, real-world treatment effectiveness, and the impact of omega-3 fatty acids on heart rhythm variability.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Collaborators (6)

Matthias Schwenkglenks

University of Zurich

SWITZERLAND

View details

Otmar Pfister

Professor

University Hospital Basel

SWITZERLAND

View details

Marco Cattaneo

University of Basel

SWITZERLAND

View details

Michael Kühne

University Hospital Basel

SWITZERLAND

View details

Steffen Blum

CANADA

View details

Alexandros Polymeris

University Hospital Basel

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Coslovsky

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

External Validation of the REACT‐HF Score for Predicting Heart Failure in Patients With Atrial Fibrillation

Cost‐Effectiveness of Drug‐Coated Balloons in the Treatment of Coronary Small Vessel Disease: A Report From the BASKET‐SMALL 2 Randomized Controlled Trial

Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation

Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation

Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial Approach

Longitudinal Changes in Health‐Related Quality of Life in Patients With Atrial Fibrillation

Mid-term changes in cognitive functions in patients with atrial fibrillation: a longitudinal analysis of the Swiss-AF cohort

Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation

Assessment of the atrial fibrillation burden in Holter electrocardiogram recordings using artificial intelligence

Bone Morphogenetic Protein 10—A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation

Silent brain infarcts impact on cognitive function in atrial fibrillation.

Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial

Collaborators (6)

Matthias Schwenkglenks

Otmar Pfister

Marco Cattaneo

Michael Kühne

Steffen Blum

Alexandros Polymeris

Make your next move.